On Monday shares of Nevro Corp. (NYSE:NVRO) closed at $53.33. Company’s EPS growth for next 5 years is recorded as 0.05%. Nevro Corp (NASDAQ:NVRO) had its price objective raised by JMP Securities from $55.00 to $65.00 in a research report released on Monday morning. JMP Securities currently has an outperform rating on the stock.
Molycorp, Inc. (NYSE:MCP) in last trading activity decreased -14.27% to close at $0.60. Company weekly performance is -32.57% while its quarterly performance stands at -17.79%. Molycorp, Inc. (NYSE:MCP) is -83.24% away from its 52 week high. Announced Amy 05, that Molycorp, Inc. (NYSE:MCP) is considering a proposal from senior creditors that would swap at least some of their bonds for equity as the rare-earths producer struggles to manage $1.6 billion of debt, according to two people with knowledge of the matter.
On Monday shares of Statoil ASA (NYSE:STO) closed at $20.64. Company’s sales growth for last 5 years was 5.60% and EPS growth for next 5 years is recorded as 2.10%. Norwegian energy firm Statoil ASA (NYSE:STO) Tuesday said Hans Jacob Hegge is appointed as new EVP and CFO. Hegge comes from the position as senior vice president for Operations North in Development & Production Norway.
Impax Laboratories Inc. (NASDAQ:IPXL) in last trading activity advanced 2.19% to close at $46.10. Company weekly performance is -0.28% while its quarterly performance stands at 17.48%. Impax Laboratories Inc. (NASDAQ:IPXL) is -14.90% away from its 52 week high. Impax Laboratories, Inc. (NASDAQ:IPXL) announced that the U.S. Food and Drug Administration (FDA) performed a three week inspection of the Company’s Hayward, California manufacturing facility. This inspection included a general GMP as well as Pre-Approval Inspections (PAI) for multiple generic products currently pending approval at the FDA. At the conclusion of the inspection on May 8, the FDA issued a Form 483 with three inspectional observations, none of which were designated as repeat observations.
On last trading day Blonder Tongue Laboratories Inc. (NYSEMKT:BDR) decreased -2.31% to close at $0.75. Its volatility for the week is 3.78% while volatility for the month is 6.94%. BDR’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was -69.50%. Blonder Tongue Laboratories Inc. (NYSEMKT:BDR) monthly performance is -5.06%. Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) announced that it will report its first quarter 2015 financial results on Thursday, May 14, 2015 prior to market opening.